Assertio Holdings Cash on Hand 2010-2024 | ASRT

Assertio Holdings cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Assertio Holdings Annual Cash on Hand
(Millions of US $)
2024 $100
2023 $73
2022 $65
2021 $37
2020 $21
2019 $42
2018 $111
2017 $128
2016 $177
2015 $210
2014 $559
2013 $272
2012 $67
2011 $86
2010 $70
2009 $70
Assertio Holdings Quarterly Cash on Hand
(Millions of US $)
2024-12-31 $100
2024-09-30 $89
2024-06-30 $88
2024-03-31 $81
2023-12-31 $73
2023-09-30 $77
2023-06-30 $70
2023-03-31 $69
2022-12-31 $65
2022-09-30 $65
2022-06-30 $52
2022-03-31 $61
2021-12-31 $37
2021-09-30 $59
2021-06-30 $54
2021-03-31 $61
2020-12-31 $21
2020-09-30 $35
2020-06-30 $59
2020-03-31 $106
2019-12-31 $42
2019-09-30 $54
2019-06-30 $75
2019-03-31 $110
2018-12-31 $111
2018-09-30 $122
2018-06-30 $57
2018-03-31 $102
2017-12-31 $128
2017-09-30 $113
2017-06-30 $117
2017-03-31 $195
2016-12-31 $177
2016-09-30 $136
2016-06-30 $118
2016-03-31 $192
2015-12-31 $210
2015-09-30 $172
2015-06-30 $118
2015-03-31 $561
2014-12-31 $559
2014-09-30 $553
2014-06-30 $218
2014-03-31 $208
2013-12-31 $272
2013-09-30 $81
2013-06-30 $70
2013-03-31 $66
2012-12-31 $67
2012-09-30 $80
2012-06-30 $72
2012-03-31 $93
2011-12-31 $86
2011-09-30 $109
2011-06-30 $114
2011-03-31 $136
2010-12-31 $70
2010-09-30 $67
2010-06-30 $67
2010-03-31 $59
2009-12-31 $70
2009-09-30 $71
2009-06-30 $68
2009-03-31 $77
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.061B $0.125B
Assertio Holdings Inc. is a specialty pharmaceutical company. Its portfolio consists of branded prescription neurology, inflammation and pain medications. The company's business development includes acquisitions, licensing and mergers. Assertio Holdings Inc., formerly known as Assertio Therapeutics Inc., is based in LAKE FOREST, Ill.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $94.222B 35.35
Zoetis (ZTS) United States $71.986B 26.86
Daiichi Sankyo, - (DSNKY) Japan $47.632B 24.23
Takeda Pharmaceutical (TAK) Japan $45.406B 9.03
Sandoz Group AG (SDZNY) Switzerland $19.756B 0.00
Summit Therapeutics (SMMT) United States $18.307B 0.00
Merck (MKKGY) Germany $17.693B 14.64
United Therapeutics (UTHR) United States $13.893B 12.29
Shionogi (SGIOY) Japan $13.832B 13.86
Neurocrine Biosciences (NBIX) United States $11.630B 39.84
IPSEN (IPSEY) France $9.997B 0.00
Orion OYJ (ORINY) Finland $8.541B 23.10
Corcept Therapeutics (CORT) United States $7.569B 61.53
Stevanato Group S.p.A (STVN) Italy $6.808B 41.63
Madrigal Pharmaceuticals (MDGL) United States $6.651B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Ionis Pharmaceuticals (IONS) United States $5.212B 0.00
Grifols, S.A (GRFS) Spain $5.019B 0.00
Soleno Therapeutics (SLNO) United States $3.843B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.062B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.776B 9.73
Hypermarcas (HYPMY) Brazil $2.407B 15.83
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.312B 12.64
NewAmsterdam Pharma (NAMS) Netherlands $2.116B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.076B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.765B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.650B 0.00
Guardian Pharmacy Services (GRDN) United States $1.613B 0.00
Indivior (INDV) United States $1.514B 6.42
Evotec AG (EVO) Germany $1.388B 0.00
ARS Pharmaceuticals (SPRY) United States $1.325B 168.62
Dyne Therapeutics (DYN) United States $1.283B 0.00
Ocular Therapeutix (OCUL) United States $1.187B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.108B 45.06
Enliven Therapeutics (ELVN) United States $0.914B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.907B 0.00
Collegium Pharmaceutical (COLL) United States $0.876B 4.73
Ardelyx (ARDX) United States $0.871B 0.00
Harrow (HROW) United States $0.865B 0.00
Xeris Biopharma Holdings (XERS) United States $0.807B 0.00
Cronos Group (CRON) Canada $0.771B 0.00
Akebia Therapeutics (AKBA) United States $0.686B 0.00
AleAnna (ANNA) United States $0.679B 0.00
Organogenesis (ORGO) United States $0.677B 0.00
Xencor (XNCR) United States $0.625B 0.00
KalVista Pharmaceuticals (KALV) United States $0.606B 0.00
Bioventus (BVS) United States $0.557B 14.17
Savara (SVRA) United States $0.556B 0.00
USANA Health Sciences (USNA) United States $0.543B 11.81
Regulus Therapeutics (RGLS) United States $0.520B 0.00
Relay Therapeutics (RLAY) United States $0.514B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.495B 0.00
Elite Pharmaceuticals (ELTP) United States $0.466B 0.00
Altimmune (ALT) United States $0.447B 0.00
Zevra Therapeutics (ZVRA) United States $0.426B 0.00
CytoDyn (CYDY) United States $0.417B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.408B 0.00
Tourmaline Bio (TRML) United States $0.404B 0.00
Verve Therapeutics (VERV) United States $0.399B 0.00
Siga Technologies (SIGA) United States $0.389B 8.12
Oruka Therapeutics (ORKA) United States $0.365B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.338B 9.13
Heron Therapeutics (HRTX) United States $0.331B 0.00
Aquestive Therapeutics (AQST) United States $0.274B 0.00
Nature's Sunshine Products (NATR) United States $0.263B 24.27
Avita Medical (RCEL) United States $0.247B 0.00
Wellgistics Health (WGRX) United States $0.216B 0.00
ProKidney (PROK) United States $0.205B 0.00
OmniAb (OABI) United States $0.192B 0.00
MediWound (MDWD) Israel $0.189B 0.00
Esperion Therapeutics (ESPR) United States $0.177B 0.00
Journey Medical (DERM) United States $0.159B 0.00
Nanobiotix S.A (NBTX) France $0.158B 0.00
Inhibikase Therapeutics (IKT) United States $0.156B 0.00
4D Molecular Therapeutics (FDMT) United States $0.150B 0.00
Profound Medical (PROF) Canada $0.150B 0.00
Korro Bio (KRRO) United States $0.145B 0.00
Larimar Therapeutics (LRMR) United States $0.143B 0.00
Aclaris Therapeutics (ACRS) United States $0.142B 0.00
Protara Therapeutics (TARA) United States $0.130B 0.00
Aldeyra Therapeutics (ALDX) United States $0.129B 0.00
Lyell Immunopharma (LYEL) United States $0.126B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.122B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Nektar Therapeutics (NKTR) United States $0.115B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.113B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.113B 0.00
Lexeo Therapeutics (LXEO) United States $0.100B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.094B 0.00
VAXART, INC (VXRT) United States $0.093B 0.00
Galectin Therapeutics (GALT) United States $0.088B 0.00
Achieve Life Sciences (ACHV) Canada $0.084B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Cassava Sciences (SAVA) United States $0.082B 0.00
Champions Oncology (CSBR) United States $0.082B 13.45
Corbus Pharmaceuticals Holdings (CRBP) United States $0.081B 0.00
Fractyl Health (GUTS) United States $0.081B 0.00
Dominari Holdings (DOMH) United States $0.078B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Unicycive Therapeutics (UNCY) United States $0.075B 0.00
Telomir Pharmaceuticals (TELO) United States $0.075B 0.00
Inotiv (NOTV) United States $0.075B 0.00
Context Therapeutics (CNTX) United States $0.069B 0.00
Pyxis Oncology (PYXS) United States $0.068B 0.00
Nutriband (NTRB) United States $0.063B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.063B 50.00
Vivani Medical (VANI) United States $0.060B 0.00
Gain Therapeutics (GANX) United States $0.060B 0.00
Metagenomi (MGX) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Karyopharm Therapeutics (KPTI) United States $0.053B 0.00
Avalo Therapeutics (AVTX) United States $0.047B 0.00
PMV Pharmaceuticals (PMVP) United States $0.046B 0.00
Century Therapeutics (IPSC) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
SCYNEXIS (SCYX) United States $0.037B 0.00
Acrivon Therapeutics (ACRV) United States $0.037B 0.00
Prelude Therapeutics (PRLD) United States $0.036B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
Rafael Holdings (RFL) United States $0.033B 0.00
FibroGen (FGEN) United States $0.032B 0.00
Surrozen (SRZN) United States $0.029B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
CASI Pharmaceuticals (CASI) China $0.024B 0.00
BioVie (BIVI) United States $0.023B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
DURECT (DRRX) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
Mannatech (MTEX) United States $0.019B 7.52
Lipocine (LPCN) United States $0.017B 0.00
Vivos Therapeutics (VVOS) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Relmada Therapeutics (RLMD) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Talphera (TLPH) United States $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.011B 8.47
Plus Therapeutics (PSTV) United States $0.011B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 3.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Carisma Therapeutics (CARM) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Jaguar Animal Health (JAGX) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Incannex Healthcare (IXHL) Australia $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00